Advisory Committee on the Medical Uses of Isotopes: Charter Renewal, 15619 [2024-04462]

Download as PDF Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated electronic, mechanical, or other technological collection techniques, or other forms of information technology, e.g., permitting electronic submissions of responses. Dated: February 27, 2024. Suzanne Mbollo, Grants Management Specialist, Institute of Museum and Library Services. I. Background NUCLEAR REGULATORY COMMISSION IMLS is the primary source of federal support for the Nation’s libraries and museums. We advance, support, and empower America’s museums, libraries, and related organizations through grant making, research, and policy development. To learn more, visit www.imls.gov. khammond on DSKJM1Z7X2PROD with NOTICES II. Current Actions This Notice proposes renewing the clearance of the content, forms, and instructions for IMLS Library and Museum Reviewer Forms for the next three years. All proposals submitted for IMLS competitive awards are reviewed by library and museum professionals who know the needs of communities, can share promising practices, and are well versed in the issues and concerns of libraries and museums today. Peer reviewers dedicate their time and expertise to advance the highest professional practices in the field. The IMLS review process is well respected, and the success of our grant programs is largely due to the expertise of our reviewers. These peer reviewer forms, accessed through the IMLS website, allow library and museum professionals to indicate their interest and provide information on their professional expertise to be considered for selection as an IMLS peer reviewer. Agency: Institute of Museum and Library Services. Title: IMLS Library and Museum Reviewer Forms. OMB Control Number: 3137–0099. Agency Number: 3137. Affected Public: Library and Museum professionals. Total Estimated Number of Annual Responses: 1,450. Frequency of Response: Once per year. Average Minutes per Response: 15. Total Estimated Annual Burden Hours: 363. Total Annual Burden: $11,649. Total Annual Federal Costs: $3,989. Public Comments Invited: Comments submitted in response to this Notice will be summarized and/or included in the request for OMB’s clearance of this information collection. VerDate Sep<11>2014 17:45 Mar 01, 2024 Jkt 262001 [FR Doc. 2024–04411 Filed 3–1–24; 8:45 am] BILLING CODE 7036–01–P Advisory Committee on the Medical Uses of Isotopes: Charter Renewal U.S. Nuclear Regulatory Commission. ACTION: Notice of renewal of the Charter of the Advisory Committee on the Medical Uses of Isotopes. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has determined that renewal of the charter for the Advisory Committee of the Medical Uses of Isotopes (ACMUI) until February 28, 2026, is in the public interest in connection with duties imposed on the Commission by law. This action is being taken in accordance with the Federal Advisory Committee Act, after consultation with the Committee Management Secretariat, General Services Administration. SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide advice to the NRC on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy. Responsibilities include providing guidance and comments on current and proposed NRC regulations and regulatory guidance concerning medical use; evaluating certain non-routine uses of byproduct material for medical use; and evaluating training and experience of proposed authorized users. The members are involved in preliminary discussions of major issues in determining the need for changes in NRC policy and regulation to ensure the continued safe use of byproduct material. Each member provides technical assistance in his/her specific area(s) of expertise, particularly with respect to emerging technologies. Members also provide guidance as to NRC’s role in relation to the responsibilities of other Federal agencies as well as of various professional organizations and boards. Members of this Committee have demonstrated professional qualifications and expertise in both scientific and non-scientific disciplines including nuclear medicine; nuclear cardiology; radiation therapy; medical physics; nuclear pharmacy; State medical regulation; patient’s rights and 15619 care; health care administration; and Food and Drug Administration regulation. Contact Information: Lillian Armstead, Office of Nuclear Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, DC 20555; email: Lillian.Armstead@ nrc.gov. Dated at Rockville, Maryland this 28th day of February, 2024. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2024–04462 Filed 3–1–24; 8:45 am] BILLING CODE 7590–01–P SUMMARY: PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 NUCLEAR REGULATORY COMMISSION [NRC–2024–0001] Sunshine Act Meetings Weeks of February March 4, 11, 18, 25, and April 1, 8, 2024. The schedule for Commission meetings is subject to change on short notice. The NRC Commission Meeting Schedule can be found on the internet at: https://www.nrc.gov/public-involve/ public-meetings/schedule.html. PLACE: The NRC provides reasonable accommodation to individuals with disabilities where appropriate. If you need a reasonable accommodation to participate in these public meetings or need this meeting notice or the transcript or other information from the public meetings in another format (e.g., braille, large print), please notify Anne Silk, NRC Disability Program Specialist, at 301–287–0745, by videophone at 240–428–3217, or by email at Anne.Silk@nrc.gov. Determinations on requests for reasonable accommodation will be made on a case-by-case basis. STATUS: Public and closed. Members of the public may request to receive the information in these notices electronically. If you would like to be added to the distribution, please contact the Nuclear Regulatory Commission, Office of the Secretary, Washington, DC 20555, at 301–415–1969, or by email at Betty.Thweatt@nrc.gov or Samantha.Miklaszewski@nrc.gov. MATTERS TO BE CONSIDERED: TIME AND DATE: Week of March 4, 2024 Thursday, March 7, 2024 10:00 a.m.—Briefing on NRC International Activities (Closed Ex. 1 and 9) E:\FR\FM\04MRN1.SGM 04MRN1

Agencies

[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Page 15619]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04462]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Charter 
Renewal

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of renewal of the Charter of the Advisory Committee on 
the Medical Uses of Isotopes.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has determined 
that renewal of the charter for the Advisory Committee of the Medical 
Uses of Isotopes (ACMUI) until February 28, 2026, is in the public 
interest in connection with duties imposed on the Commission by law. 
This action is being taken in accordance with the Federal Advisory 
Committee Act, after consultation with the Committee Management 
Secretariat, General Services Administration.

SUPPLEMENTARY INFORMATION: The purpose of the ACMUI is to provide 
advice to the NRC on policy and technical issues that arise in 
regulating the medical use of byproduct material for diagnosis and 
therapy. Responsibilities include providing guidance and comments on 
current and proposed NRC regulations and regulatory guidance concerning 
medical use; evaluating certain non-routine uses of byproduct material 
for medical use; and evaluating training and experience of proposed 
authorized users. The members are involved in preliminary discussions 
of major issues in determining the need for changes in NRC policy and 
regulation to ensure the continued safe use of byproduct material. Each 
member provides technical assistance in his/her specific area(s) of 
expertise, particularly with respect to emerging technologies. Members 
also provide guidance as to NRC's role in relation to the 
responsibilities of other Federal agencies as well as of various 
professional organizations and boards.
    Members of this Committee have demonstrated professional 
qualifications and expertise in both scientific and non-scientific 
disciplines including nuclear medicine; nuclear cardiology; radiation 
therapy; medical physics; nuclear pharmacy; State medical regulation; 
patient's rights and care; health care administration; and Food and 
Drug Administration regulation.
    Contact Information: Lillian Armstead, Office of Nuclear Material 
Safety and Safeguards, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555; email: [email protected].

    Dated at Rockville, Maryland this 28th day of February, 2024.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2024-04462 Filed 3-1-24; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.